Compounds > prostratin
Page last updated: 2024-08-24

prostratin and 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)-

prostratin has been researched along with 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)- in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deng, J; Ji, H; Jiang, Z; Li, X; Lu, H; Lu, P; Qu, X; Shen, Y; Wang, P; Yang, X; Zeng, H; Zhu, H1

Other Studies

1 other study(ies) available for prostratin and 6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)-

ArticleYear
The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb.
    Scientific reports, 2016, Apr-12, Volume: 6

    Topics: Acetanilides; CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Drug Interactions; Heterocyclic Compounds, 3-Ring; HIV-1; Humans; Lymphocyte Activation; Phorbol Esters; Positive Transcriptional Elongation Factor B; Virus Activation; Virus Latency

2016